Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase IIa Trial of Baricitinib in the Treatment of Kohlmeier-Degos Disease Patients With Neurological Involvement

Background: Kohlmeier-Degos (KD) is a rare disease that causes inflammation and blood clots, leading to blockages in small blood vessels. These blockages can …

Kohlmeier-Degos DiseaseMalignant Atrophic PapulosisDegos Disease+1 more

Estimated

~$10 – $5,625

National Heart, Lung, and Blood Institute (NHLBI)NCT06923072